SC

Suresh Chandra Srivastava

Active Director Director DIN 00831170
DIN 00831170 First appointment May 1986 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since May 1986
Shareholding value •••• Premium profile

About Suresh Chandra Srivastava

Data last updated:

Suresh Chandra Srivastava is a Director at Ess Cee Biotech (India) Private Limited (since 1986), Director at Chem Genes India Private Limited (since 2002) and Director at Milan Shyam Bio Sciences Private Limited (since 2019), and holds 2 more current directorships. The companies operate in Chemicals and Materials, Pharma and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹12.21 Cr; the largest is Ess Cee Biotech (India) Private Limited at ₹10.75 Cr (FY 2025). Earlier, Suresh Chandra Srivastava was a Director at Milan Sagar Biotech Private Limited (from 2022).

DIN 00831170
Primary Designation Director
Industry Chemicals and Materials
First Appointment 13 May 1986
Oldest Company Age 40 yrs
Largest company Ess Cee Biotech (India) Private Limited · ₹10.75 Cr (FY 2025)
Combined revenue ₹12.21 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 May 19861986₹10.75 Cr (FY 2025)Active
Chem Genes India Private Limited U24119UP2002PTC026822
Director22 Jul 20022002₹1.33 Cr (FY 2022)Active
Director24 Oct 20192019₹7.9 Lakh (FY 2024)Active
Argosy Overseas Private Limited U51109UP1989PTC218762
Director05 Dec 19991989₹4.8 Lakh (FY 2023)Active
Director24 Aug 20171992Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Milan Sagar Biotech Private Limited U24290UP2022PTC175438
Director21 Dec 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Magadh Avadh Chemical Industries Private Limited
Chem Genes India Private Limited
Milan Shyam Bio Sciences Private Limited
Argosy Overseas Private Limited
Premium access

Shareholding and investment profile for Suresh Chandra Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Chandra Srivastava

Suresh Chandra Srivastava currently holds 5 directorships: Ess Cee Biotech (India) Private Limited (Director, since 13 May 1986, revenue ₹10.75 Cr (FY 2025)); Chem Genes India Private Limited (Director, since 22 Jul 2002, revenue ₹1.33 Cr (FY 2022)); Milan Shyam Bio Sciences Private Limited (Director, since 24 Oct 2019, revenue ₹7.9 Lakh (FY 2024)); Argosy Overseas Private Limited (Director, since 05 Dec 1999, revenue ₹4.8 Lakh (FY 2023)); Magadh Avadh Chemical Industries Private Limited (Director, since 24 Aug 2017).

Suresh Chandra Srivastava was first appointed on 13 May 1986 as Director at Ess Cee Biotech (India) Private Limited. The most recent appointment on record is 21 Dec 2022 at Milan Sagar Biotech Private Limited.

The 4 current companies of Suresh Chandra Srivastava that report revenue have a combined latest revenue of ₹12.21 Cr: Ess Cee Biotech (India) Private Limited ₹10.75 Cr (FY 2025); Chem Genes India Private Limited ₹1.33 Cr (FY 2022); Milan Shyam Bio Sciences Private Limited ₹7.9 Lakh (FY 2024); Argosy Overseas Private Limited ₹4.8 Lakh (FY 2023).

Suresh Chandra Srivastava held 1 earlier board appointment: Milan Sagar Biotech Private Limited (Director, from 21 Dec 2022).

The current boards of Suresh Chandra Srivastava's companies include Sanjay Tyagi (Ess Cee Biotech (India) Private Limited), Ajay Kumar Srivastava (Chem Genes India Private Limited), Sunita Srivastava (Chem Genes India Private Limited), Umesh Kumar Maurya (Chem Genes India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available